Rate My Professor Anne Reynolds

Reynolds’ research interests center on common neonatal lung diseases related to prematurity, including optimization of pulmonary management strategies to minimize bronchopulmonary dysplasia risk in preterm neonates, neonatal nutrition to improve outcomes in low birthweight and extremely low birthweight infants, and non-pharmacologic interventions such as eat, sleep, and console for neonatal opioid withdrawal syndrome. As site principal investigator for the University at Buffalo in the Neonatal Research Network, she participates in multiple multi-center clinical trials. Selected publications include “Hydrocortisone in Preterm Infants and School-Age Functional Outcomes: Follow-Up of a Randomized Clinical Trial” (JAMA Pediatrics, 2025), “Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants: The PDA Randomized Clinical Trial” (JAMA, 2025), “Darbepoetin, Red Cell Mass, and Neuroprotection in Preterm Infants: A Randomized Clinical Trial” (JAMA Pediatrics, 2025), and “Infant Feeding and Weight Trajectories in the Eat, Sleep, Console Trial” (JAMA Pediatrics, 2024). She has earned recognition as Top Doctors in Western New York (2019-2024, 2026), GME Quality Improvement Awards (2013, 2014), and selection for Mid-Career Women Faculty Leadership Development (2018). Reynolds leads New York State Department of Health quality initiatives since 2011 on premature infant growth and reducing central line-associated bloodstream infections and teaches medical students, residents, and fellows while providing care in the 64-bed level IV regional perinatal center.